在ER阳性乳腺癌中绘制对Palbociclib的多级分子反应图
bioRxiv : the preprint server for biology
|September 5, 2025
概括
CDK4/6抑制剂可以改善乳腺癌的治疗,但耐药性是一个问题. 这项研究揭示了复杂的分子变化和反循环,
科学领域:
- 癌症学
- 分子生物学
- 基因组学
背景情况:
- 激素受体阳性,HER2阴性 (HR+/ HER2-) 乳腺癌的治疗已通过CDK4/ 6抑制剂进行.
- 患者对CDK4/ 6抑制剂的可变反应和获得的耐药性带来了重大的临床挑战.
研究的目的:
- 在乳腺癌细胞中全面定义广泛使用的CDK4/ 6抑制剂palbociclib的分子反应.
- 确定反应变异性和抗 CDK4/ 6 抑制的机制.
- 根据已明确的分子途径提名新的组合疗法.
主要方法:
- 全球基因表达分析.
- 蛋白质丰富性的蛋白质组分析.
- 另一种拼接分析.
- 染色体可访问性测试 (ATAC-seq).
主要成果:
- 抑制CDK4/6诱导广泛的分子变化,包括基因表达,蛋白质水平和替代拼接.
- 在CDK4/ 6和雌激素受体信号之间发现了一个意想不到的反循环.
- 发现了影响蛋白质功能的广泛替代拼接程序.
- 调节CDK2,CDK4/6和ERα的CDK7的共同向显示了对细胞适应性的添加效应.
结论:
- 对CDK4/ 6抑制剂的反应复杂且多层次,涉及复杂的信号网络.
- 了解这些分子变化可以了解疗效和耐药性机制.
- 针对反循环和使用组合疗法,如CDK7抑制剂,可以克服耐药性并改善HR+/ HER2乳腺癌的治疗结果.
相关概念视频
Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
Target Cell Response to Hormones
3.5K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
3.5K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


